|Bid||3,283.00 x 0|
|Ask||3,286.00 x 0|
|Day's range||3,235.00 - 3,304.00|
|52-week range||1,997.00 - 3,949.01|
|Beta (5Y monthly)||1.29|
|PE ratio (TTM)||N/A|
|Earnings date||27 Apr 2021|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||07 Nov 2019|
|1y target est||4,741.39|
Investors will keep a close tab on whether Jerome Powell will stick with the Fed's dovish stance as optimism in America’s economy grows.
The pharma company which has been looking to bring a new coronavirus vaccine to the market by the end of the year, announced it has initiated a global phase three clinical efficacy study.
With the UK economy opening up, there’s been enthusiasm to buy shares in consumer-driven businesses. But here’s one FTSE 100 stock I would avoid... for now. The post One FTSE 100 reopening stock I’m avoiding appeared first on The Motley Fool UK.